Hansoh Pharmaceutical Group Company Limited (3692.HK) HKSE
30.12
-0.9(-2.90%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 193.8B |
| Enterprise Value | 190.49B |
| P/E Ratio | 27.94 |
| PEG Ratio | 1.09 |
| Price/Sales Ratio | 10.43 |
| Price/Book Ratio | 4.39 |
| Enterprise/Revenue | 10.21 |
| Enterprise/EBITDA | 26.59 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0.37 |
| Operating Margin | 0.36 |
Management Effectiveness
| Return On Assets | 0.14 |
| Return On Equity | 0.17 |
Income Statement
| Revenue | 15.03B |
| Revenue/Share | 2.5 |
| Gross Profit | 13.51B |
| EBITDA | 5.77B |
| Net Income | 5.56B |
| Diluted EPS | 0.93 |
Balance Sheet
| Total Cash | 31.58B |
| Total Cash/Share | 5.26 |
| Total Debt | 105.14M |
| Total Debt/Equity | 0 |
| Current Ratio | 8.09 |
| Book Value Per Share | 5.89 |
Price History
| 52-Week Change | 15.23 |
| 52-Week High | 44.22 |
| 52-Week Low | 26.25 |
| Moving Average 50 Days | 36.15 |
| Moving Average 200 Days | 36.99 |
Statistics
| Average Volume | 13.05M |
| Shares Outstanding | 6.06B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.32 |
| Trailing Annual Dividend Yield | 1.22 |
| Payout Ratio | 0.36 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
